Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025

Core Viewpoint - Heron Therapeutics, Inc. will host a conference call on August 11, 2025, to report its second quarter 2025 financial results and discuss recent business highlights [1]. Group 1: Conference Call Details - The conference call is scheduled for August 11, 2025, at 4:30 p.m. ET [1]. - Participants can access the call via a registration link for dial-in details and are encouraged to join fifteen minutes early [2]. - The call will also be available as a webcast on Heron's website, with an archive accessible for 60 days post-call [2]. Group 2: Company Overview - Heron Therapeutics is a commercial-stage biotechnology company focused on developing therapeutic innovations to improve patient care [3]. - The company utilizes advanced science, patented technologies, and an innovative approach to drug discovery and development [3]. - Heron aims to advance the standard-of-care for acute care and oncology patients through its portfolio of products [3].